Literature DB >> 25034079

The tumor promoting activity of the EP4 receptor for prostaglandin E2 in murine skin.

Melissa S Simper1, Joyce E Rundhaug1, Carol Mikulec1, Rebecca Bowen1, Jianjun Shen1, Yue Lu1, Kevin Lin1, Inok Surh1, Susan M Fischer2.   

Abstract

To determine whether the EP4 receptor for prostaglandin E2 (PGE2) contributes to the tumor promoting activity of PGs in murine skin, EP4 over-expressing mice (BK5.EP4) were generated and subjected carcinogenesis protocols. An initiation/promotion protocol resulted in 25-fold more squamous cell carcinomas (SCCs) in the BK5.EP4 mice than wild type (WT) mice. An increase in SCCs also occurred following treatment with initiator alone or UV irradiation. The initiator dimethylbenz[a]anthracene caused cytotoxicity in BK5.EP4, but not WT mice, characterized by sloughing of the interfollicular epidermis, regeneration and subsequent SCC development. A comparison of transcriptomes between BK5.EP4 and WT mice treated with PGE2 showed a significant upregulation of a number of genes known to be associated with tumor development, supporting a pro-tumorigenic role for the EP4 receptor.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EP4 receptor; Murine skin; Prostaglandin E(2); Skin tumors; Tumor promotion

Mesh:

Substances:

Year:  2014        PMID: 25034079      PMCID: PMC4253556          DOI: 10.1016/j.molonc.2014.06.013

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  70 in total

Review 1.  IL-20: biological functions mediated through two types of receptor complexes.

Authors:  Ursula Maria Wegenka
Journal:  Cytokine Growth Factor Rev       Date:  2010-10-16       Impact factor: 7.638

2.  Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.

Authors:  Xiping Xin; Mousumi Majumder; Gannareddy V Girish; Vik Mohindra; Takayuki Maruyama; Peeyush K Lala
Journal:  Lab Invest       Date:  2012-05-28       Impact factor: 5.662

3.  A role for the MHC class I-like Mill molecules in nutrient metabolism and wound healing.

Authors:  Brian A Rabinovich; Randal R Ketchem; Martin Wolfson; Lynn Goldstein; Marylin Skelly; David Cosman
Journal:  Immunol Cell Biol       Date:  2008-06-17       Impact factor: 5.126

4.  The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors.

Authors:  Inok Surh; Joyce E Rundhaug; Amy Pavone; Carol Mikulec; Erika Abel; Melissa Simper; Susan M Fischer
Journal:  Mol Carcinog       Date:  2011-07-07       Impact factor: 4.784

5.  Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24.

Authors:  F Wang; N Smith; L Maier; W Xia; C Hammerberg; H Chubb; C Chen; M Riblett; A Johnston; J E Gudjonsson; Y Helfrich; S Kang; G J Fisher; J J Voorhees
Journal:  Br J Dermatol       Date:  2012-07       Impact factor: 9.302

6.  Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis.

Authors:  Yutaka Shoji; Mami Takahashi; Nobuo Takasuka; Naoko Niho; Tomohiro Kitamura; Hidetaka Sato; Takayuki Maruyama; Yukihiko Sugimoto; Shuh Narumiya; Takashi Sugimura; Keiji Wakabayashi
Journal:  Carcinogenesis       Date:  2005-07-28       Impact factor: 4.944

Review 7.  S100A8 and S100A9 in inflammation and cancer.

Authors:  Christoffer Gebhardt; Julia Németh; Peter Angel; Jochen Hess
Journal:  Biochem Pharmacol       Date:  2006-07-17       Impact factor: 5.858

8.  Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer.

Authors:  A Innamaa; L Jackson; V Asher; G van Schalkwyk; A Warren; A Keightley; D Hay; A Bali; H Sowter; R Khan
Journal:  Clin Transl Oncol       Date:  2013-03-12       Impact factor: 3.405

9.  EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.

Authors:  Giuseppe Giannini; Maria Irene Ambrosini; Lucia Di Marcotullio; Fabio Cerignoli; Massimo Zani; Andrew Ray MacKay; Isabella Screpanti; Luigi Frati; Alberto Gulino
Journal:  Mol Carcinog       Date:  2003-12       Impact factor: 4.784

10.  Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.

Authors:  Wendy Huang; Serena Ghisletti; Kaoru Saijo; Meghal Gandhi; Myriam Aouadi; Greg J Tesz; Dawn X Zhang; Joyee Yao; Michael P Czech; Bruce L Goode; Michael G Rosenfeld; Christopher K Glass
Journal:  Nature       Date:  2011-02-17       Impact factor: 49.962

View more
  10 in total

1.  Expression of prostaglandin E2 and EP receptors in human papillary thyroid carcinoma.

Authors:  Liao Sun; Xiaohong Wei; Xueting Liu; Danli Zhou; Fang Hu; Yingjuan Zeng; Ying Sun; Shunkui Luo; Yu Zhang; Xian Ping Yi
Journal:  Tumour Biol       Date:  2015-10-28

2.  Expression of prostaglandin E2 receptor subtypes in human pterygium and normal conjunctiva: immunohistochemical study.

Authors:  Erdem Dinç; Özer Dursun; Banu Yılmaz; Mustafa Vatansever; A Ayça Sarı; Özlem Yıldırım; Ufuk Adıgüzel
Journal:  Int Ophthalmol       Date:  2017-07-10       Impact factor: 2.031

3.  An Overview of Ultraviolet B Radiation-Induced Skin Cancer Chemoprevention by Silibinin.

Authors:  Rahul Kumar; Gagan Deep; Rajesh Agarwal
Journal:  Curr Pharmacol Rep       Date:  2015-06-01

4.  The tumor promoting activity of the EP4 receptor for prostaglandin E2 in murine skin.

Authors:  Melissa S Simper; Joyce E Rundhaug; Carol Mikulec; Rebecca Bowen; Jianjun Shen; Yue Lu; Kevin Lin; Inok Surh; Susan M Fischer
Journal:  Mol Oncol       Date:  2014-07-03       Impact factor: 6.603

Review 5.  Epigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequences.

Authors:  Hedi Harizi
Journal:  Mediators Inflamm       Date:  2015-04-06       Impact factor: 4.711

Review 6.  Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis.

Authors:  Gareth J Thomas; Colin A Morton
Journal:  Dermatol Ther (Heidelb)       Date:  2017-02-01

7.  Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.

Authors:  Ester Bonfill-Teixidor; Amaia Otxoa-de-Amezaga; Miriam Font-Nieves; M Glòria Sans-Fons; Anna M Planas
Journal:  J Neuroinflammation       Date:  2017-01-05       Impact factor: 8.322

Review 8.  Treatment of actinic keratosis through inhibition of cyclooxygenase-2: Potential mechanism of action of diclofenac sodium 3% in hyaluronic acid 2.5.

Authors:  Gareth J Thomas; Pedro Herranz; Susana Balta Cruz; Aurora Parodi
Journal:  Dermatol Ther       Date:  2019-04-09       Impact factor: 2.851

Review 9.  Eicosanoids in Cancer: Prostaglandin E2 Receptor 4 in Cancer Therapeutics and Immunotherapy.

Authors:  Mc Millan Ching; Jocelyn Reader; Amy M Fulton
Journal:  Front Pharmacol       Date:  2020-05-29       Impact factor: 5.810

Review 10.  New insights into the functions of Cox-2 in skin and esophageal malignancies.

Authors:  Hyeongsun Moon; Andrew C White; Alexander D Borowsky
Journal:  Exp Mol Med       Date:  2020-04-01       Impact factor: 8.718

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.